Author

Iris Dotan 1

1 Ibd Center, Department Of Gastroenterology And Liver Diseases, Tel Aviv Sourasky Medical Center And The Sackler Faculty Of Medicine, Tel Aviv, Israel

AMELIORATION OF ACTIVE ULCERATIVE COLITIS USING AN ORALLY AVAILABLE TOLL-LIKE RECEPTOR-9 MODULATOR (BL-7040): A PROSPECTIVE OPEN-LABEL, MULTI-CENTER PHASE II TRIAL

Iris Dotan, Etgar Levy-Nissenbaum, Yehuda Chowers, Alexander Fich, Eran Israeli, Tomer Adar, Shimon Shteingart, Hermona Soreq, Eran Goldin

Celltrion - Earlier Introduction of Biologics in IBD: Does It Make Sense? (Celltrion Healthcare)

Stefan Schreiber, Iris Dotan, Lissy de Ridder

COMMENSAL FUNGI AND THEIR CELL-WALL GLYCANS INDUCE AUTOPHAGY IN INTESTINAL EPITHELIAL CELLS 

Sarit Cohen-Kedar, Hofit Elad, Yulia Ron, Iris Dotan

Commensal fungi and their cell-wall β-glucans direct differential responses in human intestinal epithelial cells, suggesting a mechanism for mucosal tolerance

Sarit Cohen-Kedar, Suzana Schwartz, Eran Sadot, Meirav Wolff-Bar, Tali Shaltiel, Iris Dotan

CROHN'S DISEASE BEHAVIOR AND LOCATION IS ALTERED WHEN ASSOCIATED WITH PRIMARY SCLEROSING CHOLANGITIS

Oren Iny, Henit Yanai, Shay matalon, Erwin Santo, Oren Shibolet, Iris Dotan, Nitsan Maharshak

CROHN'S DISEASE EXCLUSION DIET INDUCES REMISSION IN ADULTS WITH MILD TO MODERATE CROHN´S DISEASE: PRELIMINARY REPORT FROM A RANDOMISED CONTROLLED TRIAL (CDED-AD TRIAL)

Henit Yanai, Arie Levine, Rotem Sigall Boneh, Nitsan Maharshak, Uri Kopylov, Joram Wardi, Lee Abramas, Naomi Fliss-Isakov, Tamar Pffefer Gik, Iris Dotan, Ayal Hirsch

Does acute ileocaecal Crohn's disease need a medical or a surgical approach? The surgeon's view

Emmanuel Tiret, Iris Dotan

DUAL OXIDASE 2, A NOVEL PLAYER IN INFLAMMATORY BOWEL DISEASE : EXPRESSION AND FUNCTIONAL IMPLICATIONS

Keren Masha Rabinoiwtz, Leah Reshef, Hofit Elad, Uri Gophna, Iris Dotan

Early Disease Acceleration in Patients with Newly Diagnosed Crohn's Disease in India and Israel: Insights from an East-west Inception Cohort

Idan Goren, Henit Yanai, Partha Pal, Bhargavi Adigopula, Sushmita Pendyala, Karin Yadgar, Rupa Banerjee, Iris Dotan

EARLY INITIATION OF ADALIMUMAB SIGNIFICANTLY DIMINISHES ENDOSCOPIC POST-OPERATIVE CROHN'S DISEASE RECURRENCE, AND IS SUPERIOR TO IMMUNOMODULATORY THERAPY, REGARDLESS OF RISK STRATIFICATION. A RANDOMIZED, CONTROLLED STUDY

Erez Scapa, Naomi Fliss-Isakov, Hagit Tulchinsky, Henit Yanai, Ian White, Iris Dotan, Nitsan Maharshak

Item 1 - 10 / 59
1
2 3 4 5 6